Joyzyme Group Limited (HKG:8622)
0.2040
-0.0210 (-9.33%)
Jun 22, 2026, 3:53 PM HKT
Joyzyme Group Market Cap
Joyzyme Group has a market cap or net worth of 115.98 million as of June 22, 2026. Its market cap has decreased by -44.16% in one year.
Market Cap
115.98M
Enterprise Value
75.97M
Revenue
31.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since December 13, 2018, Joyzyme Group's market cap has decreased from 188.00M to 115.98M, a decrease of -38.31%. That is a compound annual growth rate of -6.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 115.98M | -48.28% |
| Dec 31, 2025 | 224.23M | 198.69% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 604.52M |
| China NT Pharma Group Company | 436.54M |
| Wai Yuen Tong Medicine Holdings | 362.17M |
| Regent Pacific Group | 285.98M |
| Extrawell Pharmaceutical Holdings | 208.80M |
| Tianda Pharmaceuticals | 195.65M |
| Shenzhen Neptunus Interlong Bio-technique Company | 167.80M |
| PuraPharm Corporation | 163.19M |